Mar. 20 at 11:25 PM
$DRMA Notice of Allowance :: Product Details & New Applications ;; ((AI Research & my DD as scientist ))
🔑 "Patent focuses on Dermata’s core Spongilla technology,🌞 specifically targeting the treatment of Acne Conglobata and also new forms other types of inflammatory skin conditions.🌞
Expansion of Existing Tech: This is an Addition to their existing intellectual property (IP) portfolio. 🔑 While it ✅️ utilizes their established Spongilla (sponge-derived) platform, the allowed claims specifically cover new therapeutic applications and dosage forms that were NOT protected under their previous patents.✅️
Mechanism: 👍
$DRMA's NEW technology uses a 🌞 Unique mechanical stimulation and delivery system to penetrate the skin barrier and deliver active ingredients Deeper into the dermis 🌞 without the need for harsh chemicals."👍
(( 👍 👍 Huge New Applications for use of
$DRMA on 2 other skin diseases that 23 million people in just USA have as problems that need this product. 👍👍 ))
🌞 🌞 Bullish on ORS Meeting 3-28 to 3-31 is the Meeting for big Pharma like
$PFE will be wanting new license and funding deals in this Huge meeting of near 2600 presenting companies in show!!🌞 🌞
